We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




SBRT Can Safely Treat Multiple Metastatic Tumors

By MedImaging International staff writers
Posted on 03 May 2021
Print article
Image: SBRT can be used to treat multiple metastases (Photo courtesy of University of Chicago)
Image: SBRT can be used to treat multiple metastases (Photo courtesy of University of Chicago)
A new study suggests that stereotactic body radiotherapy (SBRT) can be used effectively for treating patients with multiple metastases.

Researchers at Fox Chase Cancer Center (Philadelphia, PA, USA), the University of Chicago Comprehensive Cancer Center (IL, USA), the University of Michigan (U-M; Ann Arbor, USA), and other institutions conducted a study involving 39 patients (mean age, 63.1; 20 57.1% male; 85.7% White) with breast, prostate, or non-small cell lung cancer (NSCLC), with at least three metastases or two metastases in close proximity. In all, 34.3% had breast cancer, 28.6% had NSCLC, and 37.1% had prostate cancer.

Dose levels were considered safe if dose-limiting toxicity (DLT) levels were observed in no more than one of six patients per location; otherwise, the dose at that location would be de-escalated. The primary end point was DLT related to SBRT within 180 days of treatment. Results of the phase one study showed that at the end of the trial period, primary six-month DLT endpoint was 0%, indicating that the approach was safe enough to begin phase 2/3 clinical trials in a larger group of patients. The study was published on April 22, 2021, in JAMA Oncology.

“People have been saying for years that if we used SBRT in patients with multiple, limited metastases, we could potentially cure more patients. But it's very technically complicated to do so,” said lead author Professor Steven Chmura, MD, PhD, of the University of Chicago. “The greatest challenge was having a whole team of people come together and figure out how we could define the doses and manage the real-time quality assurance to make sure every single patient had the best treatment possible.”

SBRT is emerging as an attractive option for treating cancers in the lung, head and neck, prostate, liver and other disease sites, with the objective of increasing local control of the target lesion while limiting dose to nearby critical structures and normal tissue. Requirements include precise localization of the target lesion in the treatment planning process; accounting for tumor motion due to respiration or other changes in the body; highly conformal dose distribution to the target volume, including a steep dose gradient to minimize radiation to surrounding healthy tissue; and image-guidance at the time of dose delivery for verification and adjustment of the target localization.

Related Links:
Fox Chase Cancer Center
University of Chicago Comprehensive Cancer Center
University of Michigan


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Color LCD
U156W
New
Powered Echocardiography Imaging/Ultrasound Table
Powered Echo
New
Ultrasound Catheter Connector Cover
ACUSON AcuNav

Print article
Radcal

Channels

MRI

view channel
Image: The pathways in the brain highlighted are those most affected by concussion (Photo courtesy of Benjamin Hacker et al)

AI Model Diagnoses Traumatic Brain Injury from MRI Scans With 99% Accuracy

A concussion is a type of traumatic brain injury that may lead to temporary disruptions in brain function. Occurring from incidents such as sports injuries, whiplash, or a simple bump to the head, many... Read more

Ultrasound

view channel
Image: The new FDA-cleared AI-enabled applications have been integrated into the EPIQ CVx and Affiniti CVx ultrasound systems (Photo courtesy of Royal Philips)

Next-Gen AI-Enabled Cardiovascular Ultrasound Platform Speeds Up Analysis

Heart failure is a significant global health challenge, affecting approximately 64 million individuals worldwide. It is associated with high mortality rates and poor quality of life, placing a considerable... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Calantic Digital Solutions is an orchestrated suite of AI radiology solutions that aims to transform radiology (Photo courtesy of Bayer)

Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions

Imaging data constitutes approximately 90% of all medical data, with the volume of such data continuously expanding, thereby significantly increasing the workload for radiologists amid existing resource limitations.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.